Sera Prognostics to Present at the 31st Annual Piper Jaffray Healthcare...
November 1, 2019 — Sera Prognostics, Inc., the leading health diagnostics company dedicated to improving the lives of women and babies through individualized prenatal care, will be presenting at the...
View ArticleSERA PROGNOSTICS RAISES $36 MILLION SERIES D FINANCING LED BY BLUE OX...
Two Strategic Healthcare Companies Join Investment Round Key Scientific Publication in Obstetrics & Gynecology Shows Sera is the Leading Authority in Assessing Preterm Birth Risk SALT LAKE CITY –...
View ArticleNEW SCIENTIFIC PUBLICATION SHOWS SERA PROGNOSTICS IS LEADER IN ASSESSING...
Highlights the Proper Experimental Design and Reporting Required for Accurate Biomarker Prediction Performance Sera Approach Exemplifies Best Practice for Building Population Screening Tests SALT LAKE...
View ArticleSera Prognostics to Present at the 38th Annual JP Morgan Healthcare Conference
January 6, 2020 — Sera Prognostics, Inc., the leading health diagnostics company dedicated to improving the lives of women and babies through individualized prenatal care, will be presenting at the...
View ArticleSERA PROGNOSTICS ANNOUNCES COMPLETION OF IMPORTANT PREVENT PTB CLINICAL...
Data quantifying the benefit of Sera’s PreTRM® strategy submitted for scientific review SALT LAKE CITY – January 9, 2020 – Sera Prognostics, Inc., the leading health diagnostics company dedicated to...
View ArticleData Confirming Performance of Sera Prognostic’s PreTRM® Test Predictor in an...
SALT LAKE CITY, January 28, 2020 — Sera Prognostics, Inc., the leading women’s precision pregnancy company, today announced two podium presentations to take place at the Society for Maternal-Fetal...
View ArticleSera Prognostics to Present at the 40th Annual Cowen Health Care Conference
February 24, 2020 — Sera Prognostics, Inc., the leading health diagnostics company dedicated to improving the lives of women and babies through individualized prenatal care, will be presenting at the...
View ArticleSera Prognostics Appoints Jay M. Moyes as Chief Financial Officer
April 2, 2020 –Salt Lake City Utah –Sera Prognostics, Inc., The Pregnancy Company, focused on improving maternal and neonatal health through innovative precision biomarker approaches, today announced...
View ArticlePublication Demonstrates Ability of Sera Prognostics’ PreTRM® Biomarker Test...
Publication Demonstrates Ability of Sera Prognostics’ PreTRM® Biomarker Test as a Predictor of Adverse Pregnancy Outcomes May 20, 2020 – SALT LAKE CITY — Sera Prognostics, Inc., The Pregnancy Company®...
View ArticleSera Prognostics Appoints Thomas J. Garite, M.D. as Vice President of...
June 24, 2020 –Salt Lake City Utah – Sera Prognostics, Inc., The Pregnancy Company, focused on improving maternal and neonatal health through innovative precision biomarker approaches, today announced...
View Article
More Pages to Explore .....